Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Mycophenolate Mofetil 250 mg Capsules vs CellCept in healthy Thai male volunteers under fasting conditions
TCTR20201118002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mycophenolate mofetil (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence endpoints. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
mycophenolate mofetil
Beyond the preview
Go deeper on TCTR20201118002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201118002.